Cardio Diagnostics Holdings, Inc. (CDIO) Stock Ticker
Market factors today
Unlock the full CDIO picture
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
CDIO stock facts
| Ticker symbol | CDIO |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $5.8M |
| CEO | Meeshanthini V. Dogan |
| Employees | 15 |
| Headquarters | Chicago, IL, US |
| IPO date | 2022-01-14 |
| Website | www.cdio.ai |
What you can see for CDIO on Tickr
Live CDIO price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CDIO report.
Rankings
FAQ
What is the ticker symbol for Cardio Diagnostics Holdings, Inc.?
The ticker symbol for Cardio Diagnostics Holdings, Inc. is CDIO, listed on the NASDAQ Capital Market.
What is CDIO?
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was…